NCT02533128

Brief Summary

Major adverse cardiovascular events (MACE) are a leading cause of serious complications and death following major noncardiac surgery. The heart biomarkers brain-type natriuretic peptide (BNP) and high-sensitivity troponin I/T (hs-TnI/T), may aid in estimating the risk of surgery - low values may permit identifying patients at a very low risk of postoperative complications, potentially helping to avoid unnecessary tests and delays prior to surgery. Recent studies suggest that the manner in which an anesthetic is conducted may have an important impact on postoperative outcomes. The combination of low blood pressure (BP) and a deep level of anesthesia despite a low dose of anesthetic - also known as a "triple low" - has been linked to increased complications and death following surgery. However, it is unclear whether triple lows actually cause postoperative complications or whether they are merely an indicator of a sick patient, who is in general more likely to suffer from cardiovascular events in the near future. To answer this question, in this study patients will be randomly assigned to groups with lower and higher blood pressures, and the postoperative rates of major adverse cardiovascular events and of relevant increases in hs-TnI (a marker of cardiac injury) compared. Another important question is that of the optimal blood pressure target during surgery. Currently there are no established methods of tailoring blood pressure management to the individual patient. In the study the investigators will perform ambulatory 24h BP measurements prior to surgery to measure the patients' average BP during sleep. In the analysis of the study data, the investigators will try to determine the relationship of preoperative biomarker levels, intraoperative BP (both in relation to fixed targets and to the patient's own night-time BP) and of anesthetic depth with the occurrence of major adverse cardiovascular events after surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
458

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 24, 2015

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 26, 2015

Completed
2 months until next milestone

Study Start

First participant enrolled

October 14, 2015

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 17, 2019

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 17, 2020

Completed
Last Updated

July 15, 2020

Status Verified

July 1, 2020

Enrollment Period

3.6 years

First QC Date

August 24, 2015

Last Update Submit

July 14, 2020

Conditions

Keywords

Intraoperative blood pressureTriple lowAnesthetic overdoseMajor adverse cardiac events (MACE)Myocardial injury after noncardiac surgery (MINS)Perioperative risk stratificationBrain-type natriuretic peptide (BNP)High-sensitivity cardiac Troponin I (hs-cTnI)

Outcome Measures

Primary Outcomes (2)

  • High-sensitivity cardiac Troponin I (hs-cTnI) > 0.04ng/ml and >= 35% relative increase compared to preoperative value

    Postoperative days 0-3

  • Major adverse cardiovascular events

    Acute coronary syndrome, new or worsening congestive heart failure, coronary revascularization, stroke, acute kidney injury, all-cause mortality

    30 days postoperatively

Secondary Outcomes (1)

  • Major adverse cardiovascular events

    1 year postoperatively

Study Arms (2)

Liberal blood pressure management

PLACEBO COMPARATOR
Drug: Liberal blood pressure management

Tight blood pressure management

ACTIVE COMPARATOR
Drug: Tight blood pressure management

Interventions

Protocolized hemodynamic management to maintain mean arterial pressure (MAP) \> 60 mmHg

Liberal blood pressure management

Protocolized hemodynamic management to maintain mean arterial pressure (MAP) \> 75 mmHg

Tight blood pressure management

Eligibility Criteria

Age45 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • A) undergoing major noncardiac surgery, defined as:
  • vascular surgery (with the exception of arteriovenous shunt, vein stripping procedures and carotid endarterectomies)
  • intraperitoneal surgery
  • intrathoracic surgery
  • major orthopedic surgery
  • B) at cardiovascular risk, defined as meeting at least 1 of the following 6 criteria:
  • history of coronary artery disease
  • history of peripheral vascular disease
  • history of stroke
  • hospitalization for congestive heart failure
  • undergoing major vascular surgery, with the exception of arteriovenous shunt, vein stripping procedures and carotid endarterectomies
  • fulfillment of any 3 of the 7 Lee criteria, defined as:
  • undergoing intrathoracic or intraperitoneal surgery
  • anamnestic transient ischemic attack (TIA)
  • any history of CHF or history of pulmonary edema
  • +4 more criteria

You may not qualify if:

  • General
  • pregnancy
  • previously enrolled in BBB Study
  • RCT
  • emergent surgery
  • presence of any active cardiac conditions:
  • unstable coronary syndromes: unstable or severe (CCS III or IV) angina
  • decompensated heart failure: NYHA IV, worsening or new-onset
  • significant arrhythmias: high-grade AV-block (Mobitz II and third-degree), symptomatic bradycardia, symptomatic ventricular arrhythmias, supraventricular arrhythmias with uncontrolled ventricular rate (\>100bpm at rest), newly recognized ventricular tachycardia
  • severe valvular disease: severe aortic stenosis (mean pressure gradient \> 40 mmHg, aortic valve area \< 1.0 cm2, symptomatic), symptomatic mitral stenosis (progressive dyspnea on exertion, externional presyncope, heart failure)
  • any transplantation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kantonsspital St. Gallen

Sankt Gallen, 9007, Switzerland

Location

Related Publications (5)

  • Sessler DI, Sigl JC, Kelley SD, Chamoun NG, Manberg PJ, Saager L, Kurz A, Greenwald S. Hospital stay and mortality are increased in patients having a "triple low" of low blood pressure, low bispectral index, and low minimum alveolar concentration of volatile anesthesia. Anesthesiology. 2012 Jun;116(6):1195-203. doi: 10.1097/ALN.0b013e31825683dc.

    PMID: 22546967BACKGROUND
  • Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Buller CE, Creager MA, Ettinger SM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Ornato JP, Page RL, Tarkington LG, Yancy CW; American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery); American Society of Echocardiography; American Society of Nuclear Cardiology; Heart Rhythm Society; Society of Cardiovascular Anesthesiologists; Society for Cardiovascular Angiography and Interventions; Society for Vascular Medicine and Biology; Society for Vascular Surgery. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation. 2007 Oct 23;116(17):e418-99. doi: 10.1161/CIRCULATIONAHA.107.185699. Epub 2007 Sep 27. No abstract available.

    PMID: 17901357BACKGROUND
  • Fleisher LA, Fleischmann KE, Auerbach AD, Barnason SA, Beckman JA, Bozkurt B, Davila-Roman VG, Gerhard-Herman MD, Holly TA, Kane GC, Marine JE, Nelson MT, Spencer CC, Thompson A, Ting HH, Uretsky BF, Wijeysundera DN. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014 Dec 9;130(24):e278-333. doi: 10.1161/CIR.0000000000000106. Epub 2014 Aug 1. No abstract available.

    PMID: 25085961BACKGROUND
  • Kristensen SD, Knuuti J, Saraste A, Anker S, Botker HE, Hert SD, Ford I, Gonzalez-Juanatey JR, Gorenek B, Heyndrickx GR, Hoeft A, Huber K, Iung B, Kjeldsen KP, Longrois D, Luscher TF, Pierard L, Pocock S, Price S, Roffi M, Sirnes PA, Sousa-Uva M, Voudris V, Funck-Brentano C; Authors/Task Force Members. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur Heart J. 2014 Sep 14;35(35):2383-431. doi: 10.1093/eurheartj/ehu282. Epub 2014 Aug 1. No abstract available.

    PMID: 25086026BACKGROUND
  • Wanner PM, Wulff DU, Djurdjevic M, Korte W, Schnider TW, Filipovic M. Targeting Higher Intraoperative Blood Pressures Does Not Reduce Adverse Cardiovascular Events Following Noncardiac Surgery. J Am Coll Cardiol. 2021 Nov 2;78(18):1753-1764. doi: 10.1016/j.jacc.2021.08.048.

MeSH Terms

Conditions

HypotensionPostoperative ComplicationsAcute Coronary SyndromeHeart FailureCoronary OcclusionStrokeAcute Kidney InjuryRenal Insufficiency, ChronicDeathCardiovascular Diseases

Condition Hierarchy (Ancestors)

Vascular DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsMyocardial IschemiaHeart DiseasesCoronary DiseaseCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesRenal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease Attributes

Study Officials

  • Miodrag Filipovic, Prof. Dr.

    Cantonal Hospital of St. Gallen

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Vice-Chairman, Clinic for Anesthesiology, Intensive Care, Prehospital and Pain Medicine

Study Record Dates

First Submitted

August 24, 2015

First Posted

August 26, 2015

Study Start

October 14, 2015

Primary Completion

May 17, 2019

Study Completion

April 17, 2020

Last Updated

July 15, 2020

Record last verified: 2020-07

Locations